The following clinical trials related to stroke at Yale-New Haven Hospital are currently undergoing relating to stroke at Yale-New Have Hospital. If you are interested in participating in any of these trials, please follow the links below. For ALIAS2 and CLEAR III, the patient must either be in the Emergency Room or admitted to the hospital with a new stroke.
- IRIS: Insulin Resistance Intervention After Stroke Trial (HIC: 0201013034)
- ALIAS2: A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection in Acute Ischemic Stroke - Part 2 (HIC: 0701002162)
- CLEAR III: Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (HIC: 0910005903)